Jazz Pharmaceuticals plc·4

Aug 12, 5:26 PM ET

McSharry Heather Ann 4

4 · Jazz Pharmaceuticals plc · Filed Aug 12, 2019

Insider Transaction Report

Form 4
Period: 2019-08-08
Transactions
  • Award

    Ordinary Shares

    2019-08-08+1,9209,424 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2019-08-08+4,8054,805 total
    Exercise: $137.12Exp: 2029-08-07Ordinary Shares (4,805 underlying)
  • Sale

    Ordinary Shares

    2019-08-09$135.65/sh787$106,7568,637 total
Footnotes (4)
  • [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 1, 2020.
  • [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F3]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.4549 to $135.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  • [F4]These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT